Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Lung Metastases|Liver Metastases
Interventions: BIOLOGICAL: MEDI6469
Sponsor: Providence Health & Services
Collaborators: Robert W. Franz Cancer Center|Providence Cancer Center, Earle A. Chiles Research Institute|MedImmune LLC